"Designing Growth Strategies is in our DNA"

Immunomodulators Market Size, Share, Trends & COVID-19 Impact Analysis, By Product Type (Immunosuppressant, Immunostimulants), By Application (Oncology, Respiratory, Multiple Sclerosis, and Others), and Regional Forecast, 2020-2027

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI104692

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Prevalence of Key Disease Conditions –Key Regions/Country
    2. New Product Launch
    3. Pipeline Analysis
    4. Impact of COVID-19 on the Immunomodulators Market
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  5. Global Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      2. Canada
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
  7. Europe Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      2. Germany
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      3. France
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      4. Spain
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      5. Italy
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      6. Scandinavia
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      7. Rest of Europe
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
  8. Asia Pacific Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      2. China
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      3. India
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      4. Australia
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      5. Southeast Asia
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      6. Rest of Asia Pacific
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
  9. Latin America Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      2. Mexico
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      3. Rest of Latin America
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
  10. Middle East & Africa Immunomodulators Market Analysis, Insights and Forecast, 2016-2027
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Product Type
      1. Immunosuppressants
      2. Immunostimulants
    3. Market Analysis, Insights and Forecast – By Application
      1. Respiratory
      2. Oncology
      3. Multiple Sclerosis
      4. Others
    4. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      2. South Africa
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
      3. Rest of Middle East & Africa
        1. By Product Type
          1. Immunosuppressants
          2. Immunostimulants
  11. Competitive Analysis
    1. Key Industry Developments
    2. Global Market Share Analysis (2019)
    3. Company Profiles (Overview, Product Types & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. F. Hoffmann-La Roche Ltd
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Novartis AG
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. Biogen
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Teva Pharmaceutical Industries Ltd.
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Amgen, Inc
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Bristol-Myers & Squibb Company
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Merck Sharp & Dohme Corp.
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      8. Eli Lilly and Company
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      9. Other Prominent Players
        1. Overview,
        2. Product Types & Services,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
  12. Strategic Recommendations
Read Less

Figure 01: Global Immunomodulators Market Value Share (%), by Region, 2019 & 2027

Figure 02: Global Immunomodulators Market Value Share (%), By Product Type, 2019 & 2027

Figure 03: Global Immunomodulators Market Forecast (USD billion), By Immunosuppressants, 2016 -2027

Figure 04: Global Immunomodulators Market Forecast (USD billion), By Immunostimulants, 2016 -2027

Figure 05: Global Immunomodulators Market Value Share (%), By Application, 2019 & 2027

Figure 06: Global Immunomodulators Market Forecast (USD billion), By Respiratory, 2016 -2027

Figure 07: Global Immunomodulators Market Forecast (USD billion), By Oncology, 2016 -2027

Figure 08: Global Immunomodulators Market Forecast (USD billion), By Multiple Sclerosis, 2016 -2027

Figure 09: Global Immunomodulators Market Forecast (USD billion), By Others, 2016 -2027

Figure 10: North America Immunomodulators Market Value (USD billion), By Country, 2019 & 2027

Figure 11: North America Immunomodulators Market Value Share (%), By Country, 2019

Figure 12: North America Immunomodulators Market Value (USD billion), By Product Type, 2019 & 2027

Figure 13: North America Immunomodulators Market Value Share (%), By Product Type, 2019

Figure 14: North America Immunomodulators Market Value (USD billion), By Application, 2019 & 2027

Figure 15: North America Immunomodulators Market Value Share (%), By Application, 2019

Figure 16: Europe Immunomodulators Market Value (USD billion), By Country, 2019 & 2027

Figure 17: Europe Immunomodulators Market Value Share (%), By Country, 2019

Figure 18: Europe Immunomodulators Market Value (USD billion), By Product Type, 2019 & 2027

Figure 19: Europe Immunomodulators Market Value Share (%), By Product Type, 2019

Figure 20: Europe Immunomodulators Market Value (USD billion), By Application, 2019 & 2027

Figure 21: Europe Immunomodulators Market Value Share (%), By Application, 2019

Figure 22: Asia Pacific Immunomodulators Market Value (USD billion), By Country, 2019 & 2027

Figure 23: Asia Pacific Immunomodulators Market Value Share (%), By Country, 2019

Figure 24: Asia Pacific Immunomodulators Market Value (USD billion), By Product Type, 2019 & 2027

Figure 25: Asia Pacific Immunomodulators Market Value Share (%), By Product Type, 2019

Figure 26: Asia Pacific Immunomodulators Market Value (USD billion), By Application, 2019 & 2027

Figure 27: Asia Pacific Immunomodulators Market Value Share (%), By Application, 2019

Figure 28: Latin America Immunomodulators Market Value (USD billion), By Country, 2019 & 2027

Figure 29: Latin America Immunomodulators Market Value Share (%), By Country, 2019

Figure 30: Latin America Immunomodulators Market Value (USD billion), By Product Type, 2019 & 2027

Figure 31: Latin America Immunomodulators Market Value Share (%), By Product Type, 2019

Figure 32: Latin America Immunomodulators Market Value (USD billion), By Application, 2019 & 2027

Figure 33: Latin America Immunomodulators Market Value Share (%), By Application, 2019

Figure 34: Middle East & Africa Immunomodulators Market Value (USD billion), By Country, 2019 & 2027

Figure 35: Middle East & Africa Immunomodulators Market Value Share (%), By Country, 2019

Figure 36: Middle East & Africa Immunomodulators Market Value (USD billion), By Product Type, 2019 & 2027

Figure 37: Middle East & Africa Immunomodulators Market Value Share (%), By Product Type, 2019

Figure 38: Middle East & Africa Immunomodulators Market Value (USD billion), By Application, 2019 & 2027

Figure 39: Middle East & Africa Immunomodulators Market Value Share (%), By Application, 2019

Figure 40: Global Immunomodulators Market Revenue (%) Share Analysis by Key Players, 2019

Table 1: Global Immunomodulators Market Revenue (USD billion) Forecast, by Region, 2016–2027

Table 2: Global Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 3: Global Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Table 4: North America Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2016–2027

Table 5: North America Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 6: North America Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Table 7: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2016–2027

Table 8: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 9: Europe Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Table 10: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2016–2027

Table 11: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 12: Asia Pacific Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Table 13: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2016–2027

Table 14: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 15: Latin America Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Table 16: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Country, 2016–2027

Table 17: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Product Type, 2016–2027

Table 18: Middle East & Africa Immunomodulators Market Revenue (USD billion) Forecast, by Application, 2016–2027

Immunomodulators Market Size, Share and Global Industry Trend Forecast till 2027
  • REPORT UPDATE
    IN PROCESS
  • 2019-2032
    (In Process)
  • 2023
    (In Process)
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase
Healthcare Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports